AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
QuidelOrtho Appoints Two Executives to Drive Quality and Innovation Globally
ByAinvest
Monday, Jul 7, 2025 7:02 am ET1min read
QuidelOrtho Corporation has appointed Devon Burek as SVP of Global Quality and Sergio Gadaleta as SVP of Clinical and Regulatory Affairs. The appointments reflect the Company's investment in operational excellence, product quality, and regulatory innovation to support global growth. Burek will lead the quality organization, while Gadaleta will oversee clinical and regulatory affairs.
QuidelOrtho Corporation (NASDAQ: QDEL) has recently bolstered its leadership team with the appointments of Devon Burek as Senior Vice President of Global Quality and Sergio Gadaleta as Senior Vice President of Clinical and Regulatory Affairs. These strategic hires underscore the company's commitment to operational excellence, product quality, and regulatory innovation to support its global growth.Devon Burek, who brings over 20 years of experience from Roche, will lead QuidelOrtho's global quality organization. Her primary focus will be on creating a streamlined, global approach to elevate product quality and enhance operational effectiveness. Prior to joining QuidelOrtho, Burek held various quality leadership roles across diagnostics and R&D at Roche.
Sergio Gadaleta, who holds a PhD in chemistry, will oversee QuidelOrtho's global clinical trial strategy and regulatory submissions. His extensive experience spans senior roles at BD, 3M, Johnson & Johnson, and the FDA. Gadaleta's strategic mindset and scientific rigor will be instrumental in guiding the company's innovations through clinical and regulatory pathways.
These appointments reflect QuidelOrtho's dedication to building a high-performance organization rooted in scientific excellence, customer trust, and global scale. The company continues to drive productivity and efficiency within its R&D team, with these additions further emphasizing its commitment to innovation and regulatory compliance.
For more information, visit quidelortho.com.
References:
[1] https://www.stocktitan.net/news/QDEL/quidel-ortho-strengthens-leadership-team-with-appointments-of-senior-sfkyzd1hmbua.html
[2] https://www.prnewswire.com/news-releases/quidelortho-strengthens-leadership-team-with-appointments-of-senior-vice-presidents-for-global-quality-and-clinical--regulatory-affairs-302498733.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet